Department Of Pediatric Oncology
Investigator
Luca Szalontay, MD
Phone
212-305-9770
Email
ls3399@cumc.columbia.edu
(Biography not available)

Clinical Studies Managed By This Investigator:
Condition Study Title
Pediatric Solid Tumors [ CLOSED ] A study in children, adolescents, and young adults recurrent or refractory solid tumors using study drug nivolumab
Cancer [ CLOSED ] Study of New Drug with Radiation Therapy in Children with Diffuse Intrinsic Pontine Gliomas (DIPG) Brain Stem Cancer
Pediatric Solid Tumors [ CLOSED ] Study of Selinexor in Pediatric Solid Tumors, including CNS Tumors
Pediatric Solid Tumors [ CLOSED ] Testing combination drugs in children with solid tumors that have come back or are resistant to current anti-cancer therapy
Solid Tumors [ CLOSED ] Study of VX15/2508 in Children, Adolescents, or Young Adults with Recurrent or Relapsed Solid Tumors
Cancer [ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years)
Cancer [ CLOSED ] Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (ages 18-21)
Cancer [ CLOSED ] Study of Flotetuzumab for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia (AML)
Cancer [ CLOSED ] Study of MTX110 in Combination with Gadolinium in Children with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas)
Brain Cancer [ CLOSED ] Study of MTX110 in Combination with Gadolinium in Children & Young Adults with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas)
Brain Tumors [ CLOSED ] Study of MTX110 in Combination with Gadolinium in Children with Newly Diagnosed Brain Cancer (Diffuse Midline Gliomas)